Data as of Jul 22
| +0.13 / +1.18%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +61.58% increase from the last price of 11.14.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.